Does the United States agree to exempt the patent of radcivir? News to be confirmed
-
Last Update: 2020-02-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On the evening of February 2, the news that "the US public safety and Health Department agreed to exempt the patent of the drug with the approval of trump, and urgently disclosed the molecular structure of the drug to China until April 27" was spread on the Internet The novel coronavirus 2019-nCoV is being developed in the Remdesivir epidemic area, and it will be good for clinical research in the Wuhan epidemic area when Reed is being developed Later, some media also quoted the news in the report, but the source is not clear The US public safety and health department and trump involved in the news didn't issue relevant statements, according to a health survey conducted by billion euro on March 3.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
